Page last updated: 2024-09-02

ta 0910 and Ataxia

ta 0910 has been researched along with Ataxia in 6 studies

*Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions. [MeSH]

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Abe, Y; Ijiro, T; Kiguchi, S; Yaguchi, A; Yokoyama, A1
Honda, M; Kimura, S; Nakamura, T; Oda, S; Ono, H; Tanabe, M1
Fujitsuka, T; Kinoshita, K; Matsuoka, Y; Yamamura, M1
Asai, H; Kinoshita, K; Matsuoka, Y; Watanabe, Y; Yamamura, M1
Fukushima, T; Kinoshita, K; Kodama, Y; Matsuoka, Y; Sugihara, J; Yamamura, M1
Kinoshita, K; Sugihara, J; Yamamura, M1

Other Studies

6 other study(ies) available for ta 0910 and Ataxia

ArticleYear
Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
    European journal of pharmacology, 2020, Sep-05, Volume: 882

    Topics: Animals; Ataxia; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Female; Glucose; Male; Mice; Oxazolidinones; Pyrrolidines; Spinocerebellar Degenerations; Thyrotropin-Releasing Hormone

2020
Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy.
    Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:12

    Topics: Animals; Ataxia; Biogenic Monoamines; Brain Stem; Cerebellum; Disease Models, Animal; Drug Administration Schedule; Mice; Mice, Neurologic Mutants; Nootropic Agents; Spinal Cord; Spinocerebellar Ataxias; Thyrotropin-Releasing Hormone

2005
Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals.
    European journal of pharmacology, 1995, Feb-14, Volume: 274, Issue:1-3

    Topics: Administration, Oral; Analysis of Variance; Animals; Ataxia; Cerebellum; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gait; Inferior Colliculi; Male; Mice; Mice, Neurologic Mutants; Pyridines; Rats; Rats, Wistar; Spinal Cord Compression; Thoracic Vertebrae; Thyrotropin-Releasing Hormone

1995
Anti-ataxic effects of TRH and its analogue, TA-0910, in Rolling mouse Nagoya by metabolic normalization of the ventral tegmental area.
    British journal of pharmacology, 1995, Volume: 116, Issue:8

    Topics: Animals; Ataxia; Energy Metabolism; Glucose; Male; Mice; Mice, Neurologic Mutants; Motor Activity; Thyrotropin-Releasing Hormone; Ventral Tegmental Area

1995
Chronic anti-ataxic actions of the novel thyrotropin-releasing hormone (TRH) analog, TA-0910, during and after repeated administration in Rolling mouse Nagoya: behavioral and pharmacokinetic studies.
    Biological & pharmaceutical bulletin, 1997, Volume: 20, Issue:1

    Topics: Animals; Ataxia; Behavior, Animal; Male; Mice; Mice, Mutant Strains; Nootropic Agents; Thyrotropin-Releasing Hormone

1997
Distribution of thyrotropin-releasing hormone (TRH) receptors in the brain of the ataxic mutant mouse, rolling mouse Nagoya.
    Biological & pharmaceutical bulletin, 1997, Volume: 20, Issue:1

    Topics: Animals; Ataxia; Brain Chemistry; Male; Mice; Mice, Mutant Strains; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone

1997